Cargando…
Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed?
See Article by Gibson et al
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474921/ https://www.ncbi.nlm.nih.gov/pubmed/30813822 http://dx.doi.org/10.1161/JAHA.119.012014 |
_version_ | 1783412681812738048 |
---|---|
author | Harrison, Robert W. Newby, L. Kristin |
author_facet | Harrison, Robert W. Newby, L. Kristin |
author_sort | Harrison, Robert W. |
collection | PubMed |
description | See Article by Gibson et al |
format | Online Article Text |
id | pubmed-6474921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64749212019-04-24 Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? Harrison, Robert W. Newby, L. Kristin J Am Heart Assoc Editorial See Article by Gibson et al John Wiley and Sons Inc. 2019-02-28 /pmc/articles/PMC6474921/ /pubmed/30813822 http://dx.doi.org/10.1161/JAHA.119.012014 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Editorial Harrison, Robert W. Newby, L. Kristin Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? |
title | Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? |
title_full | Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? |
title_fullStr | Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? |
title_full_unstemmed | Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? |
title_short | Rivaroxaban in Acute Coronary Syndromes: We Have a Compass and an Atlas, But Where Are We Headed? |
title_sort | rivaroxaban in acute coronary syndromes: we have a compass and an atlas, but where are we headed? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474921/ https://www.ncbi.nlm.nih.gov/pubmed/30813822 http://dx.doi.org/10.1161/JAHA.119.012014 |
work_keys_str_mv | AT harrisonrobertw rivaroxabaninacutecoronarysyndromeswehaveacompassandanatlasbutwhereareweheaded AT newbylkristin rivaroxabaninacutecoronarysyndromeswehaveacompassandanatlasbutwhereareweheaded |